Episode
Anthropic Enters Drug Discovery, Oura Tracks Psychedelics, Life Time Bets on GLP-1s
- Podcast
- Fitt Insider
- Published
- Jul 1, 2026
- Duration seconds
- 183
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/fitt-insider-254580/episodes/anthropic-enters-drug-discovery-oura-tracks-psychedelics-life-time-bets-on-glp-1s/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/fitt-insider-254580/anthropic-enters-drug-discovery-oura-tracks-psychedelics-life-time-bets-on-glp-1s.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
July 1, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Life Time CEO Bahram Akradi calls GLP-1 threat "a wrong bet," positioning MIORA clinics as companion to treatment as research shows pairing exercise could prevent 50,000 cardiovascular events Oura joins research initiative providing biometric data to study veterans undergoing psychedelic therapies, adding continuous physiological context to mental healthcare Anthropic launches Claude Science and internal drug discovery program focused on neglected diseases, using AI directly rather than just selling tools to life sciences companies More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → [email protected]